Clinical Trials Logo

Clinical Trial Summary

A transient ischemic attack (TIA) should be considered an emergency prevention opportunity in order to avoid recurrence as cerebral infarction (CI) serious (fatal or disabling). Indeed, about 20% of patients who have IC had in previous days or weeks, a TIA, which can be defined as a brief episode of cerebral dysfunction (or eye) do not result in permanent brain damage and thus no sequelae. Moreover, about 20% of ischemic events observed in practice are AIT. Despite the progress achieved in the treatment in the acute phase of an IC, prevention remains the most effective way to fight against this disease. This prevention can be put in place before the occurrence of a first IC, or after a first IC, especially when minor as a TIA. However, the diagnosis of TIA remains particularly difficult and it is necessary now to identify new tools for the diagnosis of transient ischemic attack. Our study focused on the identification of one or more molecules (called biological markers or biomarkers) present in the bloodstream of patients, which will serve to facilitate the differential diagnosis of patients with TIA.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02799511
Study type Interventional
Source University Hospital, Caen
Contact
Status Completed
Phase N/A
Start date March 2015
Completion date September 2019

See also
  Status Clinical Trial Phase
Completed NCT03239847 - Cost Effectiveness of the EndoPhys Pressure Sensing Access System vs. Radial A-line for Intra-operative Blood Pressure Monitoring N/A
Recruiting NCT03544801 - Renji Cerebral Small Vessel Disease Corhort Study
Recruiting NCT06010823 - Safety and Efficacy Evaluation of the Robotic Enhanced Error Training of Upper Limb Function in Post-stroke and Post TBI Participants N/A
Withdrawn NCT04991038 - Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients N/A
Recruiting NCT02472028 - Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals Phase 4
Completed NCT01915368 - Determining Optimal Post-Stroke Exercise (DOSE) N/A
Active, not recruiting NCT01555411 - Akershus Cardiac Examination (ACE) 1950 Study
Completed NCT01304576 - Orientation Agnosia: Clinical and Anatomical Study N/A
Completed NCT00059293 - Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUG
Completed NCT00049894 - Predictors of Recurrent Stroke in the PROGRESS Study N/A
Completed NCT00049920 - The ARIC MRI Study N/A
Completed NCT00005562 - Coronary Artery Calcium, Exercise Tests, and CHD Outcome N/A
Completed NCT00005395 - Honolulu Heart Program-Study of Stroke and Dementia N/A
Completed NCT00000479 - Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer Phase 3
Completed NCT00005140 - Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago N/A
Enrolling by invitation NCT00005485 - The Jackson Heart Study of Cardiovascular Disease Among African Americans
Recruiting NCT06275113 - BRING-UP Prevention
Completed NCT02702635 - Measuring Blood Flow Characteristics Using Dynamic Contrast Enhanced Magnetic Resonance Imaging N/A
Recruiting NCT04336852 - Development of a Clinically-relevant Test for Assessment of Cerebral Vascular Function N/A
Not yet recruiting NCT05892510 - Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke Phase 2/Phase 3